Gary Hodgson, Medicines Advice pharmacist at SPS, presents a summary of the resources published by SPS between 18th and 24th April.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter
Quick links to highlighted resources:   
Preparing to use omalizumab biosimilar
Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. We offer general information and implementation advice.
https://www.sps.nhs.uk/articles/preparing-to-use-omalizumab-biosimilar/
The licence and supporting evidence for omalizumab biosimilar
Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-omalizumab-biosimilar/
The licence and supporting evidence for denosumab 60mg biosimilars
Denosumab 60mg biosimilars are licensed. Learn about indications, formulations, supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-denosumab-60mg-biosimilars/
Managing pharmaceutical waste
Guidance and principles for managing waste generated from the use of medicines.
https://www.sps.nhs.uk/articles/managing-pharmaceutical-waste/
Next events – forthcoming webinars and conferences          
https://www.sps.nhs.uk/home/events/next-events/         
Join our new WhatsApp channel to stay up to date with our latest news and updates    
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i    
Podcast description:        
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.